Top of the morning to you. A sunny day is unfolding over the Pharmalot corporate campus, where a cool breeze is wafting through the windows and the early bird is devouring the scraps of food someone left on the street outside. As for us, we are brewing a delightful cup of stimulation - cinnamon cream swirl is our choice today - and readying ourselves for another round of heavy reading and reaching out to interesting people. We trust your day will be as interesting. Meanwhile, here are some tidbits. Have a good one and stay in touch...
Lilly Ends Development Of Schizophrenia Drug (Reuters)
FDA Gives Priority Review To J&J's Zytiga For Added Use (Reuters)
KV Pharma Sues Illinois Over Makena Payments (St. Louis Business Journal)
Novartis Myelofibrosis Drug Is Approved In Europe (InPharm)
FDA Panel Backs Wider Use Of Abbott's Humira (Reuters)
Achillion Pharmaceuticals Is A Takeover Target (Bloomberg News)
Making Big Bets On New Heart Drugs (Reuters)
SEC Charges Eight For Insider Trading In Sanofi Purchase (New York Times)
Roche Resubmits T-DM1 With Overall Survival Benefit (The Pink Sheet)
Will Universal Health Coverage Raise Drug Prices In India? (Pharma Times)
Novartis Smoker's Cough Drug Beats Advair In Trial (Bloomberg News)
Charles River Labs Buys Accugenix (Outsourcing Pharma)
Government Inteference Hinders Regulators In Pakistan (International News)
EDITOR'S NOTE: Please check this post for updates during the day
1 Comment